Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 57.70
-0.50 (-0.86%)
At close: Aug 18, 2026
Pet Pharm Biotech Revenue
Pet Pharm Biotech had revenue of 137.77M TWD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 265.54M, up 66.98% year-over-year. In the year 2025, Pet Pharm Biotech had annual revenue of 222.03M with 69.88% growth.
Revenue (ttm)
265.54M
Revenue Growth
+66.98%
P/S Ratio
12.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 222.03M | 91.33M | 69.88% |
| Dec 31, 2024 | 130.70M | 12.83M | 10.89% |
| Dec 31, 2023 | 117.87M | 42.13M | 55.62% |
| Dec 31, 2022 | 75.74M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.